Literature DB >> 7402800

Iron-fortified formulas and gastrointestinal symptoms in infants: a controlled study, With the cooperation of The Syracuse Consortium for Pediatric Clinical Studies.

.   

Abstract

In an attempt to determine whether iron-fortified infant formulas produced gastrointestinal symptoms in infants, we fed two similar formulas, one with and one without iron fortification, to a group of 93 term infants upon discharge from the nursery on the third day of life. Infants were fed the formulas for a period of 42 days while their mothers kept detailed daily records of all gastrointestinal symptoms. A total of 49 infants were fed the non-iron-fortified formula and 44 infants were fed the iron-fortified formula. Review of the records revealed no differences in the number of stools per day, the description of the stools, the number of days without stools, the incidence or frequency of colic, spitting-up, or vomiting. We conclude that the feeding of iron-fortified formulas to infants does not produce an increased incidence of gastrointestinal symptoms or signs.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7402800

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  4 in total

1.  Well baby visits: screening and health promotion.

Authors:  J T Rourke; L L Rourke
Journal:  Can Fam Physician       Date:  1985-05       Impact factor: 3.275

2.  Meeting the iron needs of infants and young children: an update. Nutrition Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1991-06-01       Impact factor: 8.262

3.  Infant formulas and gastrointestinal illness.

Authors:  J S Koopman; V J Turkish; A S Monto
Journal:  Am J Public Health       Date:  1985-05       Impact factor: 9.308

4.  Early iron supplementation and iron sufficiency at one month of age in NICU patients at-risk for iron deficiency.

Authors:  Timothy M Bahr; Nicholas R Carr; Thomas R Christensen; Jacob Wilkes; Elizabeth A O'Brien; Kendell R German; Robin K Ohls; Diane M Ward; Robert D Christensen
Journal:  Blood Cells Mol Dis       Date:  2021-05-06       Impact factor: 2.372

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.